FTC Sues CVS, Cigna, UnitedHealth Over Rising Insulin Costs (1)
WEB18 hours ago · Leah Nylen. The US Federal Trade Commission sued units of CVS Health Corp., Cigna Group and UnitedHealth Group Inc. on Friday, accusing the drug middlemen of engaging in illegal rebate programs that drove up the price of insulin. The agency said it filed a complaint in its administrative court alleging that CVS’s Caremark, Cigna’s Express ...
FTC Sues Prescription Drug Middlemen for Artificially Inflating …
WEB19 hours ago · Today, the Federal Trade Commission brought action against the three largest prescription drug benefit managers (PBMs)—Caremark Rx, Express Scripts (ESI), and OptumRx—and their affiliated group purchasing organizations (GPOs) for engaging in anticompetitive and unfair rebating practices that have artificially inflated the list price of insulin drugs, impaired patients’ access to lower ...
Drug middlemen illegally drive up the cost of insulin, FTC says
WEB15 hours ago · September 20, 2024 / 3:09 PM EDT / CBS News. Federal regulators are accusing the country's three largest pharmacy benefit managers of illegally driving up the cost of insulin in the U.S., while ...
FTC sues CVS, Cigna, UnitedHealth PBMs over insulin prices - STAT
WEB19 hours ago · The FTC said CVS Caremark, Cigna’s Express Scripts, and UnitedHealth’s OptumRx profit at the expense of patients forced to pay more for insulin.
FTC Sues CVS, Cigna, UnitedHealth over insulin prices
WEB14 hours ago · FTC Sues CVS, Cigna, UnitedHealth over insulin prices. ... Shares of the big PBMs’ parent companies dipped on the news, with CVS falling 1.8% at 12:58 pm. Cigna and UnitedHealth were both down ...
Feds sue pharmacy gatekeepers over high insulin costs
WEB18 hours ago · The lawsuit also follows a highly critical 71-page report on PBMs the FTC released in July. The companies have criticized the FTC over the report saying it is biased and ignores key facts about ...
US FTC sues drug 'gatekeepers' over high insulin prices
WEB18 hours ago · The FTC did not sue the three major makers of insulin, Eli Lilly (LLY.N), Sanofi (SASY.PA), and Novo Nordisk (NOVOb.CO), but it did criticise their role in what it called a broken system, and said ...
High insulin prices spur a federal lawsuit against three pharmacy ...
WEB15 hours ago · Updated 1:40 PM PDT, September 20, 2024. The federal government is suing some big pharmacy benefit managers over a system of drug rebates that regulators say has made the price of insulin soar for diabetic patients. Three companies that process about 80% of prescriptions in the United States — …
FTC sues drug 'gatekeepers' over high insulin prices - USA TODAY
WEB17 hours ago · 0:04. 1:12. The U.S. Federal Trade Commission sued the country's three largest pharmacy benefit managers on Friday, accusing them of steering diabetes patients toward higher-priced insulin to reap ...
FTC sues drug middlemen for allegedly inflating insulin prices
WEB19 hours ago · The FTC suit targets the three biggest so-called pharmacy benefit managers, UnitedHealth Group's Optum Rx, CVS Health's Caremark and Cigna's Express Scripts.